Revium Rx (RVRC) Invested Capital (2024 - 2026)

Revium Rx has disclosed Invested Capital across 3 years of filings, most recently posting $5.5 million for Q2 2026.

• In Q2 2026, Invested Capital changed N/A year-over-year to $5.5 million; the TTM figure through Jun 2026 stood at $5.5 million (changed N/A YoY), while the FY2025 annual figure was $6.9 million, down 65.46% from the prior year.
• Invested Capital came in at $5.5 million for Q2 2026 at Revium Rx, down from $6.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $19.9 million in Q4 2024 to a low of $5.5 million in Q2 2026.
• Average Invested Capital over 3 years is $10.8 million, with a median of $6.9 million recorded in 2025.
• The largest YoY upside for Invested Capital was 65.46% in 2025 against a maximum downside of 65.46% in 2025.
• Over 3 years, Invested Capital stood at $19.9 million in 2024, then slumped by 65.46% to $6.9 million in 2025, then decreased by 19.79% to $5.5 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $5.5 million in Q2 2026, $6.9 million in Q4 2025, and $19.9 million in Q4 2024.